文献速递妇科

子宫内膜异位症部分女性子宫内膜和子宫内膜瘤中干细胞性与癌症相关基因的异常表达

Aberrant expression of genes associated with stemness and cancer in endometria and endometrioma in a subset of women with endometriosis.
PubMed 文献 · Hum Reprod · 2018-01-01

研究从子宫内膜异位症患者的子宫内膜(n=18)和子宫内膜瘤(n=11)及健康女性子宫内膜(n=14)分离CD73+CD90+CD105+多能干细胞/祖细胞,并在另一组织队列(n=19)中验证。发现在小部分子宫内膜瘤样本中存在干细胞与癌症相关基因异常表达,包括KIT、HIF2α、E-cadherin、ER-β/ER-α比值改变及PTEN、ARID1A下调。

要点

  • 从子宫内膜异位症患者和健康女性子宫内膜分离的CD73+CD90+CD105+干细胞/祖细胞具有多能分化及三维球体形成能力。
  • 配对样本中子宫内膜瘤较配对子宫内膜的PTEN、ARID1A和TNFα表达显著下调(P < 0.05)。
  • 30例子宫内膜瘤样本中4例存在干细胞与癌症相关基因异常表达,作者推测可能与EAOC发生相关。

核心结论

  • 在部分卵巢子宫内膜异位症女性中鉴定出与恶性转化相关的异常基因表达特征。

研究设计与样本

  • 研究从子宫内膜异位症患者子宫内膜(n = 18)和子宫内膜瘤(n = 11)及健康女性子宫内膜(n = 14)分离CD73+CD90+CD105+多能干细胞/祖细胞进行体外分析,并在另一组织队列(n = 19)的配对子宫内膜和子宫内膜瘤组织中验证异常基因特征。
  • 子宫内膜异位症患者为ASRM III-IV期、接受腹腔镜手术者,对照子宫内膜来自健康志愿者。

主要发现

  • 来自对照组和患者组的扩增SC+细胞较SC-细胞显示显著更高的W5C5+表面表达、克隆扩增和三维球体形成能力(P < 0.05)。
  • SC+细胞可进行间充质谱系分化,而SC-细胞不能。
  • 配对样本中子宫内膜瘤较配对子宫内膜的SC+细胞PTEN、ARID1A和TNFα表达显著下调(P < 0.05)。
  • SC+队列和组织队列的层次及多变量聚类共同鉴定出30例子宫内膜瘤样本中4例存在干细胞和癌症相关基因(如KIT、HIF2α和E-cadherin)异常表达、ER-β/ER-α表达比值改变以及抑癌基因(PTEN和ARID1A)下调。

临床怎么用

  • 作者推测上述改变可能与EAOC的发生潜在相关。
  • 作者认为,在EAOC病例中进一步确认后,本研究所得知识可能有助于开发筛查方法以识别EAOC风险增加的女性。

局限性

  • 由于报道的EAOC频率非常低,本研究未能获取这些样本。
  • 采用靶向基因阵列方法可能遗漏其他与EAOC发病机制相关的潜在基因。
  • 上述标志物组合应在日后发展为EAOC的子宫内膜异位症女性的存档组织样本中进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Is there molecular evidence for a link between endometriosis and endometriosis-associated ovarian cancers (EAOC)? STUDY ANSWER: We identified aberrant gene expression signatures associated with malignant transformation in a small subgroup of women with ovarian endometriosis. WHAT IS KNOWN ALREADY: Epidemiological studies have shown an increased risk of EAOC in women with ovarian endometriosis. However, the cellular and molecular changes leading to EAOC are largely unexplored. STUDY DESIGN, SIZE, DURATION: CD73+CD90+CD105+ multipotent stem cells/progenitors (SC cohort) were isolated from endometrium (n = 18) and endometrioma (n = 11) of endometriosis patients as well as from the endometrium of healthy women (n = 14). Extensive phenotypic and functional analyses were performed in vitro on expanded multipotent stem cells/progenitors to confirm their altered characteristics. Aberrant gene signatures were also validated in paired-endometrium and -endometrioma tissue samples from another cohort (Tissue cohort, n = 19) of endometriosis patients. PARTICIPANTS/MATERIALS, SETTINGS, METHODS: Paired-endometrial and -endometriotic biopsies were obtained from women with endometriosis (ASRM stage III-IV) undergoing laparoscopic surgery. Control endometria were obtained from healthy volunteers. Isolated CD73+CD90+CD105+ SC were evaluated for the presence of known endometrial surface markers, colony forming efficiency, multi-lineage differentiation, cell cycle distribution and 3D-spheroid formation capacity. Targeted RT-PCR arrays, along with hierarchical and multivariate clustering tools, were used to determine both intergroup and intragroup gene expression variability for stem cell and cancer-associated markers, in both SC+ and tissue cohorts. MAIN RESULTS AND THE ROLE OF CHANCE: Isolated and expanded SC+ from both control and patient groups showed significantly higher surface expression of W5C5+, clonal expansion and 3D-spheroid formation capacity (P < 0.05) compared with SC-. The SC+ cells also undergo mesenchymal lineage differentiation, unlike SC-. Gene expression from paired-endometriosis samples showed significant downregulation of PTEN, ARID1A and TNFα (P < 0.05) in endometrioma compared with paired-endometrium SC+ samples. Hierarchical and multivariate clustering from both SC+ and tissue cohorts together identified 4 out of 30 endometrioma samples with aberrant expression of stem cell and cancer-associated genes, such as KIT, HIF2α and E-cadherin, altered expression ratio of ER-β/ER-α and downregulation of tumour suppressor genes (PTEN and ARID1A). Thus, we speculate that above changes may be potentially relevant to the development of EAOC. LARGE-SCALE DATA: N/A. LIMITATIONS, REASON FOR CAUTION: As the reported frequency of EAOC is very low, we did not have access to those samples in our study. Moreover, by adopting a targeted gene array approach, we might have missed several other potentially-relevant genes associated with EAOC pathogenesis. The above panel of markers should be further validated in archived tissue samples from women with endometriosis who later in life developed EAOC. WIDER IMPLICATIONS OF THE FINDINGS: Knowledge gained from this study, with further confirmation on EAOC cases, may help in developing screening methods to identify women with increased risk of EAOC. STUDY FUNDING/COMPETING INTEREST(S): The study is funded by the Swedish Research Council (2012-2844), a joint grant from Stockholm County and Karolinska Institutet (ALF), RGD network at Karolinska Institutet, Karolinska Institutet for doctoral education (KID), Estonian Ministry of Education and Research (IUT34-16), Enterprise Estonia (EU48695), Horizon 2020 innovation program (WIDENLIFE, 692065), European Union's FP7 Marie Curie Industry-Academia Partnerships and Pathways funding (IAPP, SARM, EU324509) and MSCA-RISE-2015 project MOMENDO (691058). All authors have no competing interest.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Ponandai-Srinivasan S, Andersson KL, Nister M, et al. Aberrant expression of genes associated with stemness and cancer in endometria and endometrioma in a subset of women with endometriosis. Hum Reprod. 2018. PMID: 30020448. doi:10.1093/humrep/dey241

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。